Mots C Cost

Understanding MOTS-c Cost Factors in Laboratory Procurement

The baseline MOTS-c cost for high-purity research applications ranges from $40 to $90 per 10 mg vial, depending on analytical verification, synthesis quality, and supplier standards. When evaluating acquisition expenditures, laboratory procurement specialists must look beyond the initial purchase price to consider the true cost per milligram of active, fully verified sequence.

A low nominal unit price often reflects minimal analytical oversight, unverified counter-ion content, or elevated endotoxin levels that can invalidate cell culture assays or animal studies. Institutional buyers evaluating MOTS-c must weigh the cost of raw materials against the rigorous testing protocols required to guarantee high-performance liquid chromatography (HPLC) purity and mass spectrometry sequence confirmation.

Ultimately, purchasing unverified peptides creates significant risk of baseline experimental failure, wasted laboratory hours, and non-reproducible data. Investing in certified, USA-manufactured research peptides with lot-specific documentation ensures that preclinical investigators receive uniform compound integrity across every experimental cycle.

What is MOTS-c? Molecular Structure and Mitochondrial Encoding

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino acid peptide encoded within the mitochondrial genome. Unlike classical nuclear-encoded signaling molecules, MOTS-c originates within the 12S ribosomal RNA gene of the mitochondrion, representing a unique class of mitochondrial-derived peptides (MDPs) that act as retrograde metabolic regulators.

In cell-free and cellular models, the primary sequence of MOTS-c (Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg) demonstrates specific translocational capabilities. Under metabolic stress, such as nutrient deprivation or exercise-induced signaling pathways, MOTS-c translocates from the mitochondrion to the nucleus, where it interacts with adaptive transcription factors.

Because of its unique origin and regulatory mechanics, investigators utilizing mitochondrial research compounds must account for exact primary sequence fidelity during solid-phase peptide synthesis (SPPS). Any deviation in sequence length or oxidative state of its methionine residues can dramatically alter its binding affinity and physiological activity in vitro.

Primary Preclinical Research Applications of MOTS-c

Preclinical studies indicate that MOTS-c plays a critical role in cellular energy homeostasis, metabolic regulation, and exercise-capacity pathways. In rodent models of metabolic dysfunction, administration of MOTS-c has been observed to enhance skeletal muscle insulin sensitivity, promote fatty acid oxidation, and attenuate diet-induced weight gain.

In vitro data demonstrate that MOTS-c activates the 5'-AMP-activated protein kinase (AMPK) pathway, a master regulator of cellular energy balance. This activation occurs independent of direct upstream kinase inhibition, suggesting a novel retrograde signaling cascade that restores metabolic equilibrium during cellular energetic stress.

Furthermore, investigations into physical performance and exercise capacity have documented that MOTS-c expression increases in response to acute physical exertion in animal models. Researchers studying cellular senescence, metabolic flux, and mitochondrial resilience frequently incorporate MOTS-c alongside other metabolic modulators to map out adaptive stress response networks.

Key Variables Influencing Research-Grade MOTS-c Pricing

The overall pricing structure for synthetic peptides like MOTS-c is governed by several precise manufacturing and quality assurance variables. Solid-phase peptide synthesis (SPPS) of a 16-amino acid sequence requires high-grade protected amino acid building blocks, specialized coupling reagents, and controlled reaction vessel conditions.

First, sequence complexity and purification yields impact unit costs. MOTS-c contains hydrophobic and aromatic residues—including tryptophan, tyrosine, and phenylalanine—which can promote aggregation or secondary structure formation during synthesis, reducing overall crude yield and requiring advanced purification protocols.

Second, post-synthesis processing, such as preparative reverse-phase HPLC (RP-HPLC) and lyophilization cycle optimization, drives manufacturing expense. Achieving greater than 99% purity requires multi-stage chromatographic separation, which consumes significant solvent volume and production time. Additionally, facilities operating under ISO 17025 accreditation and cGMP guidelines incur strict operational overhead that directly correlates with compound purity, stability, and safety.

Analytical Verification Requirements: RP-HPLC, Mass Spectrometry, and Endotoxin Testing

To ensure that laboratory purchases deliver scientifically sound results, every lot of MOTS-c must undergo comprehensive analytical characterization. High-Performance Liquid Chromatography (HPLC) is the gold standard for determining chromatographic purity, establishing that no truncated sequences or synthesis side-products are present.

Mass Spectrometry (MS) analysis provides crucial mass-to-charge verification, confirming that the synthesized peptide matches the theoretical molecular weight of 2174.6 Da. Without MS confirmation, HPLC alone cannot rule out sequence isomers or incorrect amino acid substitutions that may alter bioactivity.

Equally vital for cell culture and animal studies is rigorous endotoxin testing. Bacterial endotoxins (lipopolysaccharides) induce severe inflammatory responses in biological assays, producing false-positive or toxic experimental artifacts. Premium suppliers mandate chromogenic Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain below strict threshold limits (<0.1 EU/mg).

Comparative Procurement Analysis: MOTS-c vs. Humanin and SS-31

When designing mitochondrial target experiments, researchers often compare MOTS-c with complementary peptides within the same functional class, such as Humanin and SS-31. Each compound exhibits distinct structural features, synthesis yields, and associated budget allocations.

Humanin, a 24-amino acid mitochondrial-derived peptide, presents a higher synthesis barrier and lower raw purification yield than MOTS-c due to its longer sequence and propensity for self-association. Consequently, Humanin generally demands higher baseline research costs per milligram. Conversely, SS-31 (Elamipretide) is a small, synthetic tetrapeptide targeting cardiolipin in the inner mitochondrial membrane, offering streamlined synthesis dynamics but specialized salt-form requirements.

From a budgetary perspective, MOTS-c occupies a highly cost-effective middle tier, offering broad applicability across metabolic and exercise-capacity models while maintaining manageable synthesis costs per vial. Laboratories establishing comparative mitochondrial research protocols often source these compounds together to evaluate synergistic metabolic pathways.

Laboratory Reconstitution and Handling Protocols for MOTS-c

Proper reconstitution of lyophilized MOTS-c is essential to prevent peptide aggregation, precipitation, or enzymatic degradation prior to experimental use. Researchers should utilize sterile, preservative-free Bacteriostatic Water or sterile phosphate-buffered saline (PBS, pH 7.4) depending on the specific downstream assay requirements.

When preparing stock solutions, gently direct the diluent down the glass vial wall rather than directly onto the lyophilized cake. Allow the cake to hydrate naturally before applying soft rotational swirling. Vigorous shaking or vortexing must be strictly avoided, as mechanical shear stress can disrupt peptide tertiary structure and induce irreversible aggregation.

For precise concentration modeling and volumetric calculations, investigators should utilize a validated peptide reconstitution calculator to ensure accurate target dosing per reaction vessel or animal subject weight.

Storage Conditions, Lyophilization Quality, and Stability Metrics

Lyophilized MOTS-c cakes should be stored in a freezer environment at -20°C or -80°C for long-term stability. Under dry, sub-zero conditions, high-purity lyophilized MOTS-c remains stable for extended periods without significant peptide degradation or loss of biological activity.

Once reconstituted into aqueous solution, the stock solution should be aliquoted into single-use polypropylene microtubes to avoid repeated freeze-thaw cycles. Reconstituted MOTS-c aliquots maintained at 4°C should be utilized within 7 to 14 days, whereas frozen aliquots stored at -80°C maintain structural integrity for several months.

Moisture exposure represents a major threat to lyophilized peptide stability. Vials stored in sub-zero freezers must be brought to room temperature prior to opening to prevent atmospheric condensation from entering the container and compromising the peptide mass.

Bulk Sourcing and Institutional Procurement Considerations for Research Facilities

Academic institutions, biotechnology organizations, and contract research organizations (CROs) conducting high-throughput screening often require larger quantities of MOTS-c. Engaging in wholesale research peptide procurement offers significant cost-per-gram optimization while securing single-lot batch uniformity.

Acquiring an entire experimental study batch from a single production lot eliminates lot-to-lot variability, ensuring that kinetic baseline measurements remain consistent over multi-month preclinical projects. Institutional buyers should establish supplier agreements that guarantee dedicated lot reservation and full analytical transparency.

Furthermore, institutional procurement channels at PX1 Research support custom vial sizing, specialized fill finishes, and direct documentation transfer, reducing administrative friction and streamlining laboratory supply chain management.

Evaluating Supplier Standards and Certificate of Analysis Verification

Evaluating a research supplier requires thorough verification of their quality management system and lot-specific documentation. A legitimate supplier must provide a detailed Certificate of Analysis (COA) for every batch, explicitly detailing HPLC chromatograms, mass spectra, and quantitative purity percentages.

Key metrics to verify on a MOTS-c COA include:

1. Chromatographic Purity: Must meet or exceed 98% or 99% purity levels via RP-HPLC detection. 2. Mass Spectrometry Validation: Confirms exact molecular mass (2174.6 Da) without unaccounted adduct peaks. 3. Endotoxin Quantitation: Must specify LAL assay results in EU/mg. 4. Facility Compliance: Sourced from ISO 17025 accredited testing labs or cGMP-compliant manufacturing environments.

PX1 Research maintains rigorous supply chain oversight, providing USA-manufactured research peptides supported by fully transparent, lot-traceable COAs. Every shipment originates from centralized facilities in California and Arizona, backed by same-day dispatch standards for qualified order protocols.